1) BDNF pathways
BDNF传导通路
2) TrkB-BDNF signal pathway
TrkB-BDNF信号传导通路
1.
Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells;
阻断TrkB-BDNF信号传导通路对神经母细胞瘤细胞生长及凋亡的影响
3) conductive pathway
传导通路
1.
Morphological study of conductive pathways in rabbit right atrium and it s clinical value;
家兔右心房传导通路的形态学研究及其临床意义
4) signal transduction pathway
信号传导通路
1.
Signal transduction pathway of in human B lymphoma apoptosis induced by anti-IgM Daudi cell line;
Anti-IgM诱导人B淋巴瘤Daudi细胞凋亡的信号传导通路
2.
Several signal transduction pathways, such as Ras MAPK pathway, cAMP pathway, or Smads DPC4 pathway, are involved in regulating Cbfα1 activity or its expression.
多条信号传导通路如Ras MAPK、cAMP、Smads DPC4通路等涉及到Cbfα1的活性或表达的调控。
3.
The MAPK signal transduction pathway plays a pivotal role in all eukaryotic organisms.
MAPK信号传导通路在真核生物细胞的生长和分化、细胞周期调节和细胞凋亡过程中发挥着重要的作用。
5) signaling pathway
信号传导通路
1.
Lymphomas with CARMA1, BCL10, MALT1 and NF-κB signaling pathway;
CARMA1-BCL10-MALT1,NF-κB信号传导通路与淋巴瘤
2.
An integrated biological model for interferon signaling pathway and its gene polymorphisms;
干扰素信号传导通路与其基因组多态性网络模型的建立
3.
To investigate whether insulin and rapamycin can affect the activities of P~(70)S6K by the mTOR/P~(70)S6K signaling pathway in the cells of the placental tissues.
结论1、胎盘组织中P~(70)S6K蛋白的活性随着胎儿出生体重的增加而增加,P~(70)S6K的活性又受mTOR/P~(70)S6K信号传导通路的调节,这也就表明胎盘组织细胞中mTOR/P~(70)S6K信号传导通路同胎儿出生体重存在一定的联系。
6) Signal conduct access
信号传导通路
1.
Objective :To investigate the effects of radiotherapy on nuclear transcription factor-k B P65(NF-k B P65) of adenoid cystic carcinoma(ACC) cells, and to approach the regularity that radiotherapy cause to P65 signal conduct access of adenoid cystic carcinoma cells initially.
目的 研究放射治疗对人涎腺腺样囊性癌(adenoid cysticcarcinoma，ACC)细胞核转录因子NF-k B P65(nuclear transcription factor-k B P65，NF-k B P65)信号传导通路的影响，初步探讨放射线引起涎腺腺样囊性癌P65信号传导通路变化的规律。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条